742 related articles for article (PubMed ID: 35130500)
1. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA; D'Amico TA; Bentrem DJ; Chao J; Cooke D; Corvera C; Das P; Enzinger PC; Enzler T; Fanta P; Farjah F; Gerdes H; Gibson MK; Hochwald S; Hofstetter WL; Ilson DH; Keswani RN; Kim S; Kleinberg LR; Klempner SJ; Lacy J; Ly QP; Matkowskyj KA; McNamara M; Mulcahy MF; Outlaw D; Park H; Perry KA; Pimiento J; Poultsides GA; Reznik S; Roses RE; Strong VE; Su S; Wang HL; Wiesner G; Willett CG; Yakoub D; Yoon H; McMillian N; Pluchino LA
J Natl Compr Canc Netw; 2022 Feb; 20(2):167-192. PubMed ID: 35130500
[TBL] [Abstract][Full Text] [Related]
2. Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA; D'Amico TA; Bentrem DJ; Cooke D; Corvera C; Das P; Enzinger PC; Enzler T; Farjah F; Gerdes H; Gibson M; Grierson P; Hofstetter WL; Ilson DH; Jalal S; Keswani RN; Kim S; Kleinberg LR; Klempner S; Lacy J; Licciardi F; Ly QP; Matkowskyj KA; McNamara M; Miller A; Mukherjee S; Mulcahy MF; Outlaw D; Perry KA; Pimiento J; Poultsides GA; Reznik S; Roses RE; Strong VE; Su S; Wang HL; Wiesner G; Willett CG; Yakoub D; Yoon H; McMillian NR; Pluchino LA
J Natl Compr Canc Netw; 2023 Apr; 21(4):393-422. PubMed ID: 37015332
[TBL] [Abstract][Full Text] [Related]
3. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA; D'Amico TA; Almhanna K; Bentrem DJ; Chao J; Das P; Denlinger CS; Fanta P; Farjah F; Fuchs CS; Gerdes H; Gibson M; Glasgow RE; Hayman JA; Hochwald S; Hofstetter WL; Ilson DH; Jaroszewski D; Johung KL; Keswani RN; Kleinberg LR; Korn WM; Leong S; Linn C; Lockhart AC; Ly QP; Mulcahy MF; Orringer MB; Perry KA; Poultsides GA; Scott WJ; Strong VE; Washington MK; Weksler B; Willett CG; Wright CD; Zelman D; McMillian N; Sundar H
J Natl Compr Canc Netw; 2016 Oct; 14(10):1286-1312. PubMed ID: 27697982
[TBL] [Abstract][Full Text] [Related]
4. FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1.
Fashoyin-Aje L; Donoghue M; Chen H; He K; Veeraraghavan J; Goldberg KB; Keegan P; McKee AE; Pazdur R
Oncologist; 2019 Jan; 24(1):103-109. PubMed ID: 30120163
[TBL] [Abstract][Full Text] [Related]
5. [Updates and interpretation on NCCN clinical practice guidelines for gastric cancer 2017 version 5].
Qiu H; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):160-164. PubMed ID: 29492914
[TBL] [Abstract][Full Text] [Related]
6. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA; D'Amico TA; Bentrem DJ; Chao J; Corvera C; Das P; Denlinger CS; Enzinger PC; Fanta P; Farjah F; Gerdes H; Gibson M; Glasgow RE; Hayman JA; Hochwald S; Hofstetter WL; Ilson DH; Jaroszewski D; Johung KL; Keswani RN; Kleinberg LR; Leong S; Ly QP; Matkowskyj KA; McNamara M; Mulcahy MF; Paluri RK; Park H; Perry KA; Pimiento J; Poultsides GA; Roses R; Strong VE; Wiesner G; Willett CG; Wright CD; McMillian NR; Pluchino LA
J Natl Compr Canc Netw; 2019 Jul; 17(7):855-883. PubMed ID: 31319389
[TBL] [Abstract][Full Text] [Related]
7. Esophageal and esophagogastric junction cancers, version 1.2015.
Ajani JA; D'Amico TA; Almhanna K; Bentrem DJ; Besh S; Chao J; Das P; Denlinger C; Fanta P; Fuchs CS; Gerdes H; Glasgow RE; Hayman JA; Hochwald S; Hofstetter WL; Ilson DH; Jaroszewski D; Jasperson K; Keswani RN; Kleinberg LR; Korn WM; Leong S; Lockhart AC; Mulcahy MF; Orringer MB; Posey JA; Poultsides GA; Sasson AR; Scott WJ; Strong VE; Varghese TK; Washington MK; Willett CG; Wright CD; Zelman D; McMillian N; Sundar H;
J Natl Compr Canc Netw; 2015 Feb; 13(2):194-227. PubMed ID: 25691612
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the management of gastric adenocarcinoma patients.
Harada K; Lopez A; Shanbhag N; Badgwell B; Baba H; Ajani J
F1000Res; 2018; 7():. PubMed ID: 30228868
[TBL] [Abstract][Full Text] [Related]
9. Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be Enough.
Weinberg BA; Xiu J; Hwang JJ; Shields AF; Salem ME; Marshall JL
Oncologist; 2018 Oct; 23(10):1171-1177. PubMed ID: 29703766
[TBL] [Abstract][Full Text] [Related]
10. Clinical Management of Gastric Cancer Treatment Regimens.
Boilève J; Touchefeu Y; Matysiak-Budnik T
Curr Top Microbiol Immunol; 2023; 444():279-304. PubMed ID: 38231223
[TBL] [Abstract][Full Text] [Related]
11. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.
Ajani JA; Bentrem DJ; Besh S; D'Amico TA; Das P; Denlinger C; Fakih MG; Fuchs CS; Gerdes H; Glasgow RE; Hayman JA; Hofstetter WL; Ilson DH; Keswani RN; Kleinberg LR; Korn WM; Lockhart AC; Meredith K; Mulcahy MF; Orringer MB; Posey JA; Sasson AR; Scott WJ; Strong VE; Varghese TK; Warren G; Washington MK; Willett C; Wright CD; McMillian NR; Sundar H;
J Natl Compr Canc Netw; 2013 May; 11(5):531-46. PubMed ID: 23667204
[TBL] [Abstract][Full Text] [Related]
12. Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability.
Cho J; Lee J; Bang H; Kim ST; Park SH; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Kang WK; Kim S; Kim KM
Oncotarget; 2017 Feb; 8(8):13320-13328. PubMed ID: 28076847
[TBL] [Abstract][Full Text] [Related]
13. [Microsatellite Instability in Gastric Cancer].
Choda Y; Kubota T; Ishida M; Sato D; Yoshimitsu M; Nakano K; Harano M; Matsukawa H; Idani H; Shiozaki S; Okajima M
Gan To Kagaku Ryoho; 2019 Dec; 46(13):1914-1916. PubMed ID: 32157011
[TBL] [Abstract][Full Text] [Related]
14. Targeted Therapies in Advanced Gastric Cancer.
Patel TH; Cecchini M
Curr Treat Options Oncol; 2020 Jul; 21(9):70. PubMed ID: 32725377
[TBL] [Abstract][Full Text] [Related]
15. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.
Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Ribeiro RRE; de Castria TB; Zilberstein B; Alves VAF; Ribeiro U; de Mello ES
Mol Diagn Ther; 2019 Dec; 23(6):761-771. PubMed ID: 31595457
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan.
Yoshida T; Ogura G; Tanabe M; Hayashi T; Ohbayashi C; Azuma M; Kunisaki C; Akazawa Y; Ozawa S; Matsumoto S; Suzuki T; Mitoro A; Fukunaga T; Shimizu A; Fujimoto G; Yao T
Cancer Biol Ther; 2022 Dec; 23(1):191-200. PubMed ID: 35220884
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.
Choi YY; Kim H; Shin SJ; Kim HY; Lee J; Yang HK; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Choi SH; Hong S; Kim JW; Hyung WJ; Noh SH; Cheong JH
Ann Surg; 2019 Aug; 270(2):309-316. PubMed ID: 29727332
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
[TBL] [Abstract][Full Text] [Related]
19. [Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment].
Cohen R; Pudlarz T; Garcia-Larnicol ML; Vernerey D; Dray X; Clavel L; Jary M; Piessen G; Zaanan A; Aparicio T; Louvet C; Tournigand C; Chibaudel B; Tougeron D; Guimbaud R; Benouna J; Adenis A; Sokol H; Borg C; Duval A; Svrcek M; André T
Bull Cancer; 2020 Apr; 107(4):438-446. PubMed ID: 32057467
[TBL] [Abstract][Full Text] [Related]
20. SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma.
Rivera F; Grávalos C; García-Carbonero R;
Clin Transl Oncol; 2012 Jul; 14(7):528-35. PubMed ID: 22721798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
